By Daniela Torres

Image by Yuchaxz, cc 4.0 via Wikimedia Commons

April 13, 2023 (San Diego) -- U.S. District Judge Matthew Kacsmaryk in Texas has ruled to suspend the approval of mifepristone, a medication that has on the market for over two decades. But Thomas O. Rice, a federal judge from the state of Washington, has issued an opposite ruling, ordering that no changes be made that would restrict mifepristone. The conflicting rulings leave women and medical providers in limbo, with appeals to higher courts in the works to resolve the conflicting decisions.